These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34379195)

  • 1. Authors' Response: COVID-19 in Children with Asthma.
    Chatziparasidis G; Kantar A
    Lung; 2021 Aug; 199(4):437-438. PubMed ID: 34379195
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: Nationwide real-world evidence.
    Adir Y; Humbert M; Saliba W
    J Allergy Clin Immunol; 2021 Aug; 148(2):361-367.e13. PubMed ID: 34144110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologics may have a beneficial effect in asthma patients with COVID-19.
    Izquierdo JL; Soriano JB
    Eur Respir J; 2021 Aug; 58(2):. PubMed ID: 34244322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 in a patient with severe asthma treated with Omalizumab.
    Lommatzsch M; Stoll P; Virchow JC
    Allergy; 2020 Oct; 75(10):2705-2708. PubMed ID: 32544254
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of the COVID-19 pandemic in children with allergic asthma.
    Ruano FJ; Somoza Álvarez ML; Haroun-Díaz E; Vázquez de la Torre M; López González P; Prieto-Moreno A; Torres Rojas I; Cervera García MD; Pérez Alzate D; Blanca-López N; Canto Díez G
    J Allergy Clin Immunol Pract; 2020 Oct; 8(9):3172-3174.e1. PubMed ID: 32730834
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe asthma and COVID-19: lessons from the first wave.
    Patrucco F; Benfante A; Villa E; Principe S; Scichilone N; Solidoro P
    J Asthma; 2022 Feb; 59(2):239-242. PubMed ID: 33297799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [COVID-19, severe asthma, and biologic].
    Underner M; Taillé C; Peiffer G; Perriot J; Jaafari N
    Rev Mal Respir; 2021 Apr; 38(4):423-426. PubMed ID: 33771438
    [No Abstract]   [Full Text] [Related]  

  • 8. COVID-19 in a severe eosinophilic asthmatic receiving benralizumab - a case study.
    Renner A; Marth K; Patocka K; Pohl W
    J Asthma; 2021 Sep; 58(9):1270-1272. PubMed ID: 32519921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [COVID-19 and asthma].
    Louis R; Calmes D; Frix AN; Schleich F
    Rev Med Liege; 2020 Sup; 75(S1):130-132. PubMed ID: 33211435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ongoing asthma management in children during the COVID-19 pandemic: to step down or not to step down?
    Abrams EM; Szefler S
    Lancet Respir Med; 2021 Aug; 9(8):820-822. PubMed ID: 34252377
    [No Abstract]   [Full Text] [Related]  

  • 11. Asthma and atopy in COVID-19: 2021 updates.
    Carr TF; Kraft M
    J Allergy Clin Immunol; 2022 Feb; 149(2):562-564. PubMed ID: 34942236
    [No Abstract]   [Full Text] [Related]  

  • 12. High levels of anxiety during the COVID-19 pandemic as a risk factor of clinical worsening in patients with severe asthma.
    Lacwik P; Szydłowska D; Kupczyk M; Pałczyński C; Kuna P
    J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1381-1383. PubMed ID: 33440258
    [No Abstract]   [Full Text] [Related]  

  • 13. Pediatric Asthma Health Care Utilization, Viral Testing, and Air Pollution Changes During the COVID-19 Pandemic.
    Taquechel K; Diwadkar AR; Sayed S; Dudley JW; Grundmeier RW; Kenyon CC; Henrickson SE; Himes BE; Hill DA
    J Allergy Clin Immunol Pract; 2020; 8(10):3378-3387.e11. PubMed ID: 32827728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled budesonide for early treatment of COVID-19 - Authors' reply.
    Ramakrishnan S; Bafadhel M
    Lancet Respir Med; 2021 Jul; 9(7):e61. PubMed ID: 33991509
    [No Abstract]   [Full Text] [Related]  

  • 15. Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation.
    Beurnier A; Jutant EM; Jevnikar M; Boucly A; Pichon J; Preda M; Frank M; Laurent J; Richard C; Monnet X; Duranteau J; Harrois A; Chaumais MC; Bellin MF; Noël N; Bulifon S; Jaïs X; Parent F; Seferian A; Savale L; Sitbon O; Montani D; Humbert M
    Eur Respir J; 2020 Nov; 56(5):. PubMed ID: 32732333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing asthma exacerbations in children following COVID-19 infection.
    Barrows J; Morphew T; Ehwerhemuepha L; Galant SP
    J Allergy Clin Immunol Pract; 2024 Jan; 12(1):229-231.e1. PubMed ID: 37806437
    [No Abstract]   [Full Text] [Related]  

  • 17. COVID-19 in patients with severe asthma using biological agents.
    Aksu K; Demir Ş; Topel M; Yeşilkaya S; Ateş H; Koca Kalkan İ; Öncül A; Çuhadar Erçelebi D; Türkyılmaz S
    Tuberk Toraks; 2021 Sep; 69(3):433-436. PubMed ID: 34581170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of COVID-19 on Patient-Initiated Discontinuation of Omalizumab in Two Academic Hospital Clinics at the University of Toronto.
    Seung Kim JH; Georgakopoulos JR; Yeung J
    J Cutan Med Surg; 2020; 24(5):534-535. PubMed ID: 33023343
    [No Abstract]   [Full Text] [Related]  

  • 19. Montelukast's ability to fight COVID-19 infection.
    Bozek A; Winterstein J
    J Asthma; 2021 Oct; 58(10):1348-1349. PubMed ID: 32586154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infection with SARS-CoV-2 among children with asthma: evidence from Global Asthma Network.
    Chiang CY; Ellwood P; Ellwood E; García-Marcos L; Masekela R; Asher I; Badellino H; Sanz AB; Douros K; El Sony A; Diaz CG; Rodríguez MA; Moreno-Salvador A; Pérez-Martini LF; Filho NR; Shpakou A; Sulaimanov S; Tavakol M; Valverde-Molina J; Yousef AA; Pearce N;
    Pediatr Allergy Immunol; 2022 Jan; 33(1):e13709. PubMed ID: 34856034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.